A randomized, triple-blinded controlled clinical study with a novel disease-modifying drug combination in equine lameness-associated osteoarthritis

por Skiöldebrand, E., Adepu, S., Lützelschwab, C., Nyström, S., Lindahl, A., Abrahamsson-Aurell, K., Hansson, E.
Publicado 2023

Salivary biglycan-neo-epitope-BGN(262): A novel surrogate biomarker for equine osteoarthritic sub-chondral bone sclerosis and to monitor the effect of short-term training and surfa...

por Adepu, S., Lord, M., Hugoh, Z., Nyström, S., Mattsson-Hulten, L., Abrahamsson-Aurell, K., Lützelschwab, C., Skiöldebrand, E.
Publicado 2023